Put Options

26 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $190,155 - $230,020
3,500 New
3,500 $208,000
Q1 2024

May 07, 2024

BUY
$54.2 - $69.69 $12.3 Million - $15.8 Million
226,400 New
226,400 $15.7 Million
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $196,092 - $251,979
3,900 Added 29.32%
17,200 $998,000
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $59,664 - $86,128
1,600 Added 13.68%
13,300 $715,000
Q1 2023

May 16, 2023

SELL
$37.61 - $45.72 $63,937 - $77,724
-1,700 Reduced 12.69%
11,700 $464,000
Q4 2022

Feb 14, 2023

SELL
$31.9 - $41.95 $1.27 Million - $1.67 Million
-39,800 Reduced 74.81%
13,400 $539,000
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $32,326 - $46,844
1,400 Added 2.7%
53,200 $1.58 Million
Q1 2022

May 16, 2022

BUY
$26.91 - $47.15 $279,864 - $490,360
10,400 Added 25.12%
51,800 $1.46 Million
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $751,716 - $1.3 Million
22,800 Added 122.58%
41,400 $1.91 Million
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $127,104 - $172,752
4,800 Added 34.78%
18,600 $610,000
Q2 2021

Aug 11, 2021

BUY
$31.86 - $38.6 $105,138 - $127,380
3,300 Added 31.43%
13,800 $484,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $247,080 - $314,418
-8,700 Reduced 45.31%
10,500 $379,000
Q4 2020

Feb 16, 2021

SELL
$23.69 - $31.47 $78,177 - $103,851
-3,300 Reduced 14.67%
19,200 $558,000
Q3 2020

Nov 16, 2020

SELL
$26.38 - $33.1 $931,214 - $1.17 Million
-35,300 Reduced 61.07%
22,500 $635,000
Q2 2020

Aug 14, 2020

BUY
$29.93 - $50.1 $1.34 Million - $2.24 Million
44,700 Added 341.22%
57,800 $1.87 Million
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $600,930 - $1.33 Million
-19,800 Reduced 60.18%
13,100 $534,000
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $1.96 Million - $2.81 Million
-35,200 Reduced 51.69%
32,900 $2.03 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $1.12 Million - $1.48 Million
17,300 Added 34.06%
68,100 $4.96 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $1.8 Million - $2.19 Million
26,600 Added 109.92%
50,800 $4.18 Million
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $490,381 - $754,778
10,700 Added 79.26%
24,200 $1.71 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $111,159 - $152,388
-2,700 Reduced 16.67%
13,500 $608,000
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $804,840 - $1.08 Million
-15,200 Reduced 48.41%
16,200 $916,000
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $3.02 Million - $3.65 Million
-53,600 Reduced 63.06%
31,400 $2.1 Million
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $1.28 Million - $1.63 Million
22,500 Added 36.0%
85,000 $4.95 Million
Q4 2017

Feb 14, 2018

SELL
$53.3 - $74.56 $26,650 - $37,280
-500 Reduced 0.79%
62,500 $4.03 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $2.74 Million - $3.31 Million
63,000
63,000 $3.31 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.